{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:27Z","timestamp":1772165667304,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Cancer Institute, United States","award":["1U54CA190151-01"],"award-info":[{"award-number":["1U54CA190151-01"]}]},{"name":"National Cancer Institute, United States","award":["1U54CA190151-01"],"award-info":[{"award-number":["1U54CA190151-01"]}]},{"name":"National Cancer Institute, United States","award":["1U54CA190151-01"],"award-info":[{"award-number":["1U54CA190151-01"]}]},{"name":"National Cancer Institute, United States","award":["P30 CA082709"],"award-info":[{"award-number":["P30 CA082709"]}]},{"name":"National Cancer Institute, United States","award":["1U54CA190151-01"],"award-info":[{"award-number":["1U54CA190151-01"]}]},{"name":"National Cancer Institute, United States","award":["1U54CA190151-01"],"award-info":[{"award-number":["1U54CA190151-01"]}]},{"name":"National Cancer Institute, United States","award":["P30 CA082709"],"award-info":[{"award-number":["P30 CA082709"]}]},{"name":"National Cancer Institute, United States","award":["P30 CA082709"],"award-info":[{"award-number":["P30 CA082709"]}]},{"name":"National Cancer Institute, United States","award":["P30 CA082709"],"award-info":[{"award-number":["P30 CA082709"]}]},{"name":"National Cancer Institute, United States","award":["1U54CA190151-01"],"award-info":[{"award-number":["1U54CA190151-01"]}]},{"name":"National Cancer Institute, United States","award":["1U54CA190151-01"],"award-info":[{"award-number":["1U54CA190151-01"]}]},{"name":"National Cancer Institute, United States","award":["1U54CA190151-01"],"award-info":[{"award-number":["1U54CA190151-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cervical cancer is caused by oncogenic human papillomaviruses (HR-HPV) and is common among Kenyan women. Identification of factors that increase HR-HPV persistence is critically important. Kenyan women exposed to aflatoxin have an increased risk of HR-HPV detection in cervical specimens. This analysis was performed to examine associations between aflatoxin and HR-HPV persistence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Kenyan women were enrolled in a prospective study. The analytical cohort for this analysis included 67 HIV-uninfected women (mean age 34 years) who completed at least two of three annual study visits and had an available blood sample. Plasma aflatoxin was detected using ultra-high pressure liquid chromatography (UHPLC)-isotope dilution mass spectrometry. Annual cervical swabs were tested for HPV (Roche Linear Array). Ordinal logistic regression models were fitted to examine associations of aflatoxin and HPV persistence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Aflatoxin was detected in 59.7% of women and was associated with higher risk of persistent detection of any HPV type (OR\u2009=\u20093.03, 95%CI\u2009=\u20091.08\u20138.55,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.036), HR-HPV types (OR\u2009=\u20093.63, 95%CI\u2009=\u20091.30-10.13,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.014), and HR-HPV types not included in the 9-valent HPV vaccine (OR\u2009=\u20094.46, 95%CI\u2009=\u20091.13\u201317.58,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.032).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Aflatoxin detection was associated with increased risk of HR-HPV persistence in Kenyan women. Further studies, including mechanistic studies are needed to determine if aflatoxin synergistically interacts with HR-HPV to increase cervical cancer risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08323-8","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T14:59:20Z","timestamp":1686063560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association of plasma aflatoxin with persistent detection of oncogenic human papillomaviruses in cervical samples from Kenyan women enrolled in a longitudinal study"],"prefix":"10.1186","volume":"23","author":[{"given":"Yan","family":"Tong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Tonui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omenge","family":"Orang\u2019o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Titus","family":"Maina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kapten","family":"Muthoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Groopman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Madeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Ermel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Loehrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darron R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"key":"8323_CR1","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:398\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"8323_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S2214-109X(20)30459-9","volume":"9","author":"D Stelzle","year":"2020","unstructured":"Stelzle D, Tanaka LF, Lee KK, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2020;9:161\u20139.","journal-title":"Lancet Glob Health"},{"key":"8323_CR3","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.3332\/ecancer.2022.1442","volume":"16","author":"V Mwenda","year":"2022","unstructured":"Mwenda V, Mburu W, Bor JP, et al. Cervical cancer programme, Kenya, 2011\u20132020: lessons to guide elimination as a public health problem. Ecancermedicalscience. 2022;16:1442.","journal-title":"Ecancermedicalscience"},{"key":"8323_CR4","unstructured":"Organization WH. Cervical cancer Kenya 2021 country profile. Available at: https:\/\/www.who.int\/publications\/m\/item\/cervical-cancer-ken-country-profile-2021."},{"key":"8323_CR5","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/jnci\/djr235","volume":"103","author":"V Brower","year":"2011","unstructured":"Brower V. AIDS-related cancers increase in Africa. J Natl Cancer Inst. 2011;103:918\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"8323_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.[see comment]. J Pathol. 1999;189:12\u20139.","journal-title":"J Pathol"},{"key":"8323_CR7","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1093\/jnci\/djq356","volume":"102","author":"SK Kjaer","year":"2010","unstructured":"Kjaer SK, Frederiksen K, Munk C, Iftner T. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010;102:1478\u201388.","journal-title":"J Natl Cancer Inst"},{"key":"8323_CR8","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","volume":"9","author":"D Stelzle","year":"2021","unstructured":"Stelzle D, Tanaka LF, Lee KK, et al. Estimates of the global burden of cervical cancer associated with HIV. The lancet global health. 2021;9:e161\u2013e9.","journal-title":"The lancet global health"},{"key":"8323_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","volume":"32","author":"G Liu","year":"2018","unstructured":"Liu G, Sharma M, Tan N, Barnabas RV. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer. AIDS. 2018;32:795\u2013808.","journal-title":"AIDS"},{"key":"8323_CR10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12879-019-3982-7","volume":"19","author":"A Ermel","year":"2019","unstructured":"Ermel A, Tonui P, Titus M, et al. A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected kenyan women. BMC Infect Dis. 2019;19:352.","journal-title":"BMC Infect Dis"},{"key":"8323_CR11","doi-asserted-by":"publisher","first-page":"205031212094513","DOI":"10.1177\/2050312120945138","volume":"8","author":"Y Tong","year":"2020","unstructured":"Tong Y, Tonui P, Ermel A, et al. Persistence of oncogenic and non-oncogenic human papillomavirus is associated with human immunodeficiency virus infection in kenyan women. SAGE Open Med. 2020;8:2050312120945138.","journal-title":"SAGE Open Med"},{"key":"8323_CR12","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1289\/ehp.1104357","volume":"120","author":"YY Gong","year":"2012","unstructured":"Gong YY, Wilson S, Mwatha JK, et al. Aflatoxin exposure may contribute to chronic hepatomegaly in kenyan school children. Environ Health Perspect. 2012;120:893\u20136.","journal-title":"Environ Health Perspect"},{"key":"8323_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12550-018-0314-5","volume":"34","author":"A Seetha","year":"2018","unstructured":"Seetha A, Monyo ES, Tsusaka TW, et al. Aflatoxin-lysine adducts in blood serum of the malawian rural population and aflatoxin contamination in foods (groundnuts, maize) in the corresponding areas. Mycotoxin Res. 2018;34:195\u2013204.","journal-title":"Mycotoxin Res"},{"key":"8323_CR14","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1186\/s12889-018-6164-4","volume":"18","author":"S Watson","year":"2018","unstructured":"Watson S, Moore SE, Darboe MK, et al. Impaired growth in rural gambian infants exposed to aflatoxin: a prospective cohort study. BMC Public Health. 2018;18:1247.","journal-title":"BMC Public Health"},{"key":"8323_CR15","doi-asserted-by":"publisher","unstructured":"Zhang J, Orang\u2019o O, Tonui P, et al. Detection and concentration of plasma aflatoxin is associated with detection of oncogenic human papillomavirus in Kenyan women. Open Forum Infect Dis. 2019;6(9):ofz354. https:\/\/doi.org\/10.1093\/ofid\/ofz354.","DOI":"10.1093\/ofid\/ofz354"},{"key":"8323_CR16","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1080\/07853890.2022.2067897","volume":"54","author":"Y Tong","year":"2022","unstructured":"Tong Y, Orang\u2019o E, Nakalembe M, et al. The East Africa Consortium for human papillomavirus and cervical cancer in women living with HIV\/AIDS. Ann Med. 2022;54:1202\u201311.","journal-title":"Ann Med"},{"key":"8323_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1086\/426867","volume":"191","author":"DR Brown","year":"2005","unstructured":"Brown DR, Shew ML, Qadadri B, et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis. 2005;191:182\u201392.","journal-title":"J Infect Dis"},{"key":"8323_CR18","first-page":"1","volume":"90","author":"WHO","year":"2007","unstructured":"WHO. Human papillomaviruses. IARC Working Group on the evaluation of carcinogenic risks to humans. IARC Monogr. 2007;90:1\u2013636.","journal-title":"IARC Monogr"},{"key":"8323_CR19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518\u201327.","journal-title":"N Engl J Med"},{"key":"8323_CR20","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1158\/1055-9965.EPI-07-2780","volume":"17","author":"LF McCoy","year":"2008","unstructured":"McCoy LF, Scholl PF, Sutcliffe AE, et al. Human aflatoxin albumin adducts quantitatively compared by ELISA, HPLC with fluorescence detection, and HPLC with isotope dilution mass spectrometry. Cancer Epidemiol Biomarkers Prev. 2008;17:1653\u20137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"8323_CR21","doi-asserted-by":"publisher","first-page":"e0189255","DOI":"10.1371\/journal.pone.0189255","volume":"12","author":"JW Smith","year":"2017","unstructured":"Smith JW, Kroker-Lobos MF, Lazo M, et al. Aflatoxin and viral hepatitis exposures in Guatemala: molecular biomarkers reveal a unique profile of risk factors in a region of high liver cancer incidence. PLoS ONE. 2017;12:e0189255.","journal-title":"PLoS ONE"},{"key":"8323_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.fct.2014.09.016","volume":"74","author":"JD Groopman","year":"2014","unstructured":"Groopman JD, Egner PA, Schulze KJ, et al. Aflatoxin exposure during the first 1000 days of life in rural South Asia assessed by aflatoxin B(1)-lysine albumin biomarkers. Food Chem Toxicol. 2014;74:184\u20139.","journal-title":"Food Chem Toxicol"},{"key":"8323_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/aje\/kwn036","volume":"168","author":"J Koshiol","year":"2008","unstructured":"Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol. 2008;168:123\u201337.","journal-title":"Am J Epidemiol"},{"key":"8323_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/ijc.29719","volume":"138","author":"S Stensen","year":"2016","unstructured":"Stensen S, Kjaer SK, Jensen SM, et al. Factors associated with type-specific persistence of high-risk human papillomavirus infection: a population-based study. Int J Cancer. 2016;138:361\u20138.","journal-title":"Int J Cancer"},{"key":"8323_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1128\/CMR.16.3.497-516.2003","volume":"16","author":"JW Bennett","year":"2003","unstructured":"Bennett JW, Klich M. Mycotoxins Clin Microbiol Rev. 2003;16:497\u2013516.","journal-title":"Mycotoxins Clin Microbiol Rev"},{"key":"8323_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/carcin\/bgp264","volume":"31","author":"CP Wild","year":"2010","unstructured":"Wild CP, Gong YY. Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis. 2010;31:71\u201382.","journal-title":"Carcinogenesis"},{"key":"8323_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1289\/ehp.5753","volume":"111","author":"PC Turner","year":"2003","unstructured":"Turner PC, Moore SE, Hall AJ, Prentice AM, Wild CP. Modification of immune function through exposure to dietary aflatoxin in gambian children. Environ Health Perspect. 2003;111:217\u201320.","journal-title":"Environ Health Perspect"},{"key":"8323_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.taap.2008.04.004","volume":"231","author":"GM Meissonnier","year":"2008","unstructured":"Meissonnier GM, Pinton P, Laffitte J, et al. Immunotoxicity of aflatoxin B1: impairment of the cell-mediated response to vaccine antigen and modulation of cytokine expression. Toxicol Appl Pharmacol. 2008;231:142\u20139.","journal-title":"Toxicol Appl Pharmacol"},{"key":"8323_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2217\/fmb.13.166","volume":"9","author":"PE Jolly","year":"2014","unstructured":"Jolly PE. Aflatoxin: does it contribute to an increase in HIV viral load? Future Microbiol. 2014;9:121\u20134.","journal-title":"Future Microbiol"},{"key":"8323_CR30","doi-asserted-by":"publisher","first-page":"5884","DOI":"10.1002\/jsfa.9240","volume":"98","author":"K Shirani","year":"2018","unstructured":"Shirani K, Zanjani BR, Mahmoudi M, et al. Immunotoxicity of aflatoxin M1: as a potent suppressor of innate and acquired immune systems in a subacute study. J Sci Food Agric. 2018;98:5884\u201392.","journal-title":"J Sci Food Agric"},{"key":"8323_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejca.2018.02.010","volume":"94","author":"YJ Chu","year":"2018","unstructured":"Chu YJ, Yang HI, Wu HC, et al. Aflatoxin B1 exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumption. Eur J Cancer. 2018;94:37\u201346.","journal-title":"Eur J Cancer"},{"key":"8323_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.fct.2018.11.047","volume":"124","author":"BR Rushing","year":"2019","unstructured":"Rushing BR, Selim MI. Aflatoxin B1: a review on metabolism, toxicity, occurrence in food, occupational exposure, and detoxification methods. Food Chem Toxicol. 2019;124:81\u2013100.","journal-title":"Food Chem Toxicol"},{"key":"8323_CR33","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/19440049.2011.647098","volume":"29","author":"M Carvajal","year":"2012","unstructured":"Carvajal M, Berumen J, Guardado-Estrada M. The presence of aflatoxin B(1)-FAPY adduct and human papilloma virus in cervical smears from cancer patients in Mexico. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2012;29:258\u201368.","journal-title":"Food Addit Contam Part A Chem Anal Control Expo Risk Assess"},{"key":"8323_CR34","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1093\/ajcn\/80.5.1106","volume":"80","author":"JH Williams","year":"2004","unstructured":"Williams JH, Phillips TD, Jolly PE, Stiles JK, Jolly CM, Aggarwal D. Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. Am J Clin Nutr. 2004;80:1106\u201322.","journal-title":"Am J Clin Nutr"},{"key":"8323_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijfoodmicro.2008.01.008","volume":"124","author":"JM Wagacha","year":"2008","unstructured":"Wagacha JM, Muthomi JW. Mycotoxin problem in Africa: current status, implications to food safety and health and possible management strategies. Int J Food Microbiol. 2008;124:1\u201312.","journal-title":"Int J Food Microbiol"},{"key":"8323_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/10408398.2010.535718","volume":"53","author":"GJ Gnonlonfin","year":"2013","unstructured":"Gnonlonfin GJ, Hell K, Adjovi Y, et al. A review on aflatoxin contamination and its implications in the developing world: a sub-saharan african perspective. Crit Rev Food Sci Nutr. 2013;53:349\u201365.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"8323_CR37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.socscimed.2015.10.039","volume":"146","author":"JL Leroy","year":"2015","unstructured":"Leroy JL, Wang JS, Jones K. Serum aflatoxin B(1)-lysine adduct level in adult women from Eastern Province in Kenya depends on household socio-economic status: a cross sectional study. Soc Sci Med. 2015;146:104\u201310.","journal-title":"Soc Sci Med"},{"key":"8323_CR38","doi-asserted-by":"publisher","first-page":"101930","DOI":"10.1016\/j.canep.2021.101930","volume":"72","author":"DM Ba","year":"2021","unstructured":"Ba DM, Ssentongo P, Musa J, et al. Prevalence and determinants of cervical cancer screening in five sub-saharan african countries: a population-based study. Cancer Epidemiol. 2021;72:101930.","journal-title":"Cancer Epidemiol"},{"key":"8323_CR39","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1186\/s12889-022-13750-4","volume":"22","author":"GC Chirwa","year":"2022","unstructured":"Chirwa GC. Explaining socioeconomic inequality in cervical cancer screening uptake in Malawi. BMC Public Health. 2022;22:1376.","journal-title":"BMC Public Health"},{"key":"8323_CR40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1146\/annurev.publhealth.29.020907.090859","volume":"29","author":"JD Groopman","year":"2008","unstructured":"Groopman JD, Kensler TW, Wild CP. Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries. Annu Rev Public Health. 2008;29:187\u2013203.","journal-title":"Annu Rev Public Health"},{"issue":"2","key":"8323_CR41","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/toxins13020104","volume":"13","author":"F Peles","year":"2021","unstructured":"Peles F, Sipos P, Kovacs S, Gyori Z, Pocsi I, Pusztahelyi T. Biological control and mitigation of aflatoxin contamination in commodities. Toxins (Basel). 2021;13(2):104. https:\/\/doi.org\/10.3390\/toxins13020104.","journal-title":"Toxins (Basel)"},{"issue":"3","key":"8323_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/toxins13030204","volume":"13","author":"P Sipos","year":"2021","unstructured":"Sipos P, Peles F, Brasso DL, et al. Physical and chemical methods for reduction in aflatoxin content of feed and food. Toxins (Basel). 2021;13(3):204. https:\/\/doi.org\/10.3390\/toxins13030204.","journal-title":"Toxins (Basel)"},{"key":"8323_CR43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/09540105.2015.1079600","volume":"27","author":"F Saeed","year":"2016","unstructured":"Saeed F, Nadeem M, Ahmed R, Nadeem M, Arshad M, Ullah A. Studying the impact of nutritional immunology underlying the modulation of immune responses by nutritional compounds \u2013 a review. Food and Agricultural Immunology. 2016;27:205\u201329.","journal-title":"Food and Agricultural Immunology"},{"key":"8323_CR44","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2174\/1874357901206010198","volume":"6","author":"PE Gravitt","year":"2012","unstructured":"Gravitt PE. Evidence and impact of human papillomavirus latency. Open Virol J. 2012;6:198\u2013203.","journal-title":"Open Virol J"},{"key":"8323_CR45","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/jmv.22116","volume":"83","author":"B Weaver","year":"2011","unstructured":"Weaver B, Shew M, Qadadri B, et al. Low-level persistence of human papillomavirus 16 DNA in a cohort of closely followed adolescent women. J Med Virol. 2011;83:1362\u20139.","journal-title":"J Med Virol"},{"key":"8323_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.pvr.2018.01.001","volume":"5","author":"A Ermel","year":"2018","unstructured":"Ermel A, Shew ML, Imburgia TM, et al. Redetection of human papillomavirus type 16 infections of the cervix in mid-adult life. Papillomavirus Res. 2018;5:75\u20139.","journal-title":"Papillomavirus Res"},{"key":"8323_CR47","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/infdis\/jiaa557","volume":"223","author":"P Paul","year":"2021","unstructured":"Paul P, Hammer A, Rositch AF, et al. Rates of New Human Papillomavirus Detection and loss of detection in Middle-aged women by recent and past sexual behavior. J Infect Dis. 2021;223:1423\u201332.","journal-title":"J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08323-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08323-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08323-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T18:01:41Z","timestamp":1686074501000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08323-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8323"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08323-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2468599\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"11 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study approval was granted from the local review board at Moi Teaching and Referral Hospital (MTRH) and Moi University, Eldoret, Kenya, the Kenya Medical Research Institute\u2019s Scientific and Ethics Review Unit (KEMRI-SERU) and the Institutional Review Board of Indiana University. All participants provided written informed consent, either in Swahili or English, for participation in the study and for use of clinical specimens. All study procedures were performed in accordance with relevant guidelines and regulations outlined by the Ethics Review Boards indicated above.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Brown currently receives research funding and has received royalties and consulting fees in the past from Merck and Co., Inc.  Dr. Brown serves on the Scientific Advisory Board for PDS, Inc.The other Authors do not possess any potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"377"}}